Legal access to marijuana is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to a new study published in the journal Complementary Therapies in Medicine.
New research shows that those suffering from persistent pain who use marijuana on a daily basis are less likely to use opioids that fall outside of prescribed guidelines.
The research was published in the journal PLOS One – the name of the study is Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis.
Orally consumed cannabinoids “provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain”, according to a new study published in the journal Neuropsychopharmacology.
According to a new study published in the journal Frontiers in Neurology, the daily use of cannabidiol (CBD) is associated with the improvement of symptoms in adolescents related to autism spectrum disorder.
CBD could “significantly reduce opioid use and improve chronic pain and sleep quality among patients who are currently using opioids for pain management”, according to a new study.
The study, titled Evaluations of effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study, was published in the journal Postgraduate Medicine.
Inhaling marijuana is associated with reductions in headache and migraine severity, according to a new study published in the Journal of Pain, and published by the National Institute of Health.
The study, titled Short and Long-term effects of cannabis on headaches and migraine, can be found by clicking here.
According to a newly released study subjects who consumed cannabis typically decrease their driving speed and demonstrated few other significant changes.
The study, titled Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects, was published in the journal Drug and Alcohol Dependence.
According to the results of a small pilot study vaping CBD products might lead to a positive urine test for marijuana.
The study tested people after use of cannabidiol (CBD) samples, some containing tiny amounts of THC (the psychoactive ingredient in marijuana), reports Reuters. One-third of those who vaped CBD-dominant cannabis had positive urine tests for THC, according to the report in the Journal of Analytical Toxicology.
The use of cannabis or cannabis-related products is associated with subjective benefits in women with endometriosis. This is according to a new study, titled Self-reported efficacy of cannabis for endometriosis pain, which was published in the Journal of Minimally Invasive Oncology.
According to a new study – titled A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers – around six in ten primary care physicians believe that medical cannabis is a “legitimate” therapeutic option. The study was published in the journal BMC Family Practice.